Skip to content

Claire Jordan Wiggins, MD

NPI 1508431867ActiveIndividual· Dermatology· Houston, TX

Dermatology (MD) in Houston, Texas, trained at Baylor College of Medicine (class of 2021). Part D covered 497 prescriptions written in 2024, 91% of them generic. Arcutis Biotherapeutics, Inc. was the largest of 12 companies reporting payments in 2025, $7,454 in all, mostly food and beverage.

Overview

NPI1508431867
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedMay 20, 2021
Last updated in NPPESSep 1, 2026
Certified by providerSep 1, 2026

Specialties and licenses

TaxonomyCodeLicenseState
Dermatology Primary207N00000XW7490TX

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Dermatology (OR); Practitioner - Dermatology (TX); Practitioner - Dermatology (WA)

Part D prescriptions in 2024

Prescriptions (claims)497 · 591 30-day fills
Patients210
Total drug cost$300,543
Generic share91% of claims

Medicare sources and data years

Education and affiliations

Medical schoolBaylor College of Medicine
Graduation year2021
Medicare specialtyDermatology

Medical group

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$7,454 · 100 payments from 12 companies
  • 2024$3,767 · 81 payments from 17 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$3,962 · 96 payments
  • Consulting Fee$2,200 · 1 payment
  • Travel and Lodging$1,292 · 3 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other dermatologists in Houston

All 239 dermatologists in Houston · All dermatologists in Texas